|
Visual inspection during the investigation, no significant deformations or damages of the valves were determined.Permeability test a permeability test has shown that both valves are permeable.Computer controlled test to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical position.The result shows that the m.Blue operates not within the accepted tolerances in the vertical position.However, the progav 2.0 operates within the specified tolerances in the horizontal position.An accelerated outflow of m.Blue in the vertical position could be determined.Adjustment test the valves were tested and both valves are adjustable in all pressure settings.Braking force and brake function test the brake functionality test has shown that the brake function operates as expected and the braking force is within the given tolerance.Internal inspection after dismantling of the valves, organic deposits were found in both valves.Results based on our investigation results, we can determine that there is accelerated outflow at m.Blue.The deposits visible in the valve led to a change in the flow rate.Furthermore, we can determine visible deposits in progav 2.0.The deposits did not affect the technical properties at the time of the investigation.Deposits caused by natural substances found in the body, such as protein, blood, or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of organic deposits can compromise the integrity of the valve.The examination of the returned product is complete with the creation of this report.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|